SeaStar Medical Holding Corporation (ICU)
ICU Stock Price Chart
Explore SeaStar Medical Holding Corporation interactive price chart. Choose custom timeframes to analyze ICU price movements and trends.
ICU Company Profile
Discover essential business fundamentals and corporate details for SeaStar Medical Holding Corporation (ICU) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Mar 2021
Employees
19.00
Website
https://www.seastarmedical.comCEO
Eric Schlorff
Description
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
ICU Financial Timeline
Browse a chronological timeline of SeaStar Medical Holding Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.18 surpassing the estimated -$0.43 by +58.14%, while revenue for the quarter reached $338.00K , beating expectations by +12.67%.
Earnings released on 14 May 2025
EPS came in at -$0.44 surpassing the estimated -$0.52 by +15.38%, while revenue for the quarter reached $293.00K , beating expectations by +95.33%.
Earnings released on 27 Mar 2025
EPS came in at -$0.90 falling short of the estimated -$0.89 by -1.12%, while revenue for the quarter reached $67.00K , missing expectations by -55.33%.
Earnings released on 13 Nov 2024
EPS came in at -$1.10 surpassing the estimated -$1.13 by +2.65%, while revenue for the quarter reached $68.00K , missing expectations by -54.67%.
Earnings released on 13 Aug 2024
EPS came in at -$1.03 surpassing the estimated -$1.41 by +26.95%.
Stock split effective on 10 Jun 2024
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2024
EPS came in at -$4.75 falling short of the estimated -$0.15 by -3.07K%.
Earnings released on 16 Apr 2024
EPS came in at -$4.75 falling short of the estimated -$0.13 by -3.55K%.
Earnings released on 14 Nov 2023
EPS came in at -$3.00 falling short of the estimated -$0.25 by -1.10K%.
Earnings released on 14 Aug 2023
EPS came in at -$6.25 falling short of the estimated -$0.25 by -2.40K%.
Earnings released on 15 May 2023
EPS came in at -$10.00 falling short of the estimated -$5.00 by -100.00%.
Earnings released on 30 Mar 2023
EPS came in at -$58.32 .
Earnings released on 30 Sept 2022
EPS came in at -$3.72 .
Earnings released on 16 Aug 2022
EPS came in at -$3.12 .
Earnings released on 31 Mar 2022
EPS came in at -$3.47 .
Earnings released on 31 Dec 2021
EPS came in at $0.22 .
Earnings released on 30 Sept 2021
EPS came in at $0.45 .
Earnings released on 30 Jun 2021
EPS came in at -$2.18 .
Earnings released on 31 Mar 2021
EPS came in at -$2.04 .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 .
ICU Stock Performance
Access detailed ICU performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.